Avanir Faces Investor Suit Over 'Tax Deductible' Claims
Avanir Pharmaceuticals Inc. was hit with a proposed class action Tuesday accusing the firm of misleading investors ahead of a shareholder vote that it could give out tax-deductible performance executive compensation...To view the full article, register now.
Already a subscriber? Click here to view full article